The article “Effects of Artesunate on the Expressions of Insulin-Like Growth Factor-1, Osteopontin and C-Telopeptides of Type II Collagen in a Rat Model of Osteoarthritis” [Pharmacology. 2017;101(1–2):1–8, https://doi.org/10.1159/000479160] by Zhe Bai, Xiao-Hui Guo, Chi Tang, Si-Tong Yue, Long Shi and Bo Qiang has been retracted by the Publisher and the Editor.
Following publication, concerns were raised regarding the data presented in the article. Specifically, there appears to be an internal duplication between an area of Figure 2c and Figure 2d of this article representing the artesunate group and Viatril-S group, respectively.
The authors did not respond to requests to comment on the concerns within the given timeframe despite multiple attempts of contact. The matter has been raised to the corresponding author’s institution who did not respond to our request for an investigation. Given the image concerns raised and the absence of a response, this article is being retracted.
The authors have not responded to our correspondence regarding this retraction despite multiple attempts of contact.
© 2024 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2024
